Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 12.5B | 14.4B | 13.1B | 13.3B |
| Cost of revenue | 9.7B | 11.5B | 10.5B | 10.5B |
| Gross profit | 2.7B | 2.8B | 2.7B | 2.9B |
| Operating expense | ||||
| Research & development | 492M | 503M | 370M | 403M |
| Selling general and admin | 1.3B | 1.5B | 1.5B | 1.3B |
| Other operating expenses | 39M | 178M | 90M | 62M |
| Operating income | 1.1B | 826M | 909M | 1.2B |
| Non operating interest income | ||||
| Income | 107M | 110M | 120M | 96M |
| Expense | 79M | 212M | 50M | 39M |
| Other income expense | — | — | — | — |
| Pretax income | 1.1B | 538M | 943M | 1.1B |
| Tax provision | 309M | -265M | 316M | 344M |
| Net income | 799M | 803M | 627M | 789M |
| Basic EPS | 0.5 | — | 0.4 | 0.5 |
| Diluted EPS | 0.5 | — | 0.4 | 0.5 |
| Basic average shares | 1.6B | — | 1.6B | 1.6B |
| Diluted average shares | 1.6B | — | 1.6B | 1.6B |
| EBITDA | 1.5B | 1.1B | 1.3B | 1.5B |
| Net income from continuing op. | 1.1B | 538M | 944M | 1.1B |
| Minority interests | -28M | -56M | -17M | -47M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |